BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1
955 results:

  • 1. Cancer stem cells: The important role of CD markers, Signaling pathways, and MicroRNAs.
    Gholamzad A; Khakpour N; Khosroshahi EM; Asadi S; Koohpar ZK; Matinahmadi A; Jebali A; Rashidi M; Hashemi M; Sadi FH; Gholamzad M
    Pathol Res Pract; 2024 Apr; 256():155227. PubMed ID: 38490099
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center.
    Singh M; Sharma P; Bhatia P; Trehan A; Thakur R; Sreedharanunni S
    BMC Cancer; 2024 Mar; 24(1):325. PubMed ID: 38459434
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Renin-Angiotensin System Inhibitors Suppress the Growth of leukemia Cells.
    Itoh M; Sasaki S; Tohda S
    Anticancer Res; 2024 Mar; 44(3):1183-1192. PubMed ID: 38423665
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Effect of Ferroptosis Inducers and Inhibitors on Cell Proliferation in Acute leukemia.
    Kumada H; Itoh M; Tohda S
    Anticancer Res; 2024 Mar; 44(3):1003-1010. PubMed ID: 38423654
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Williams-Beuren syndrome in pediatric T-cell acute lymphoblastic leukemia: A rare case report and review of literature.
    Yang R; Ai Y; Bai T; Lu XX; He G
    Medicine (Baltimore); 2024 Feb; 103(7):e36976. PubMed ID: 38363891
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Thymic-Epithelial-Cell-Dependent Microenvironment Influences Proliferation and Apoptosis of Leukemic Cells.
    Patel SK; Zhdanovskaya N; Sergio I; Cardinale A; Rosichini M; Varricchio C; Pace E; Capalbo C; Locatelli F; Macone A; Velardi E; Palermo R; Felli MP
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338689
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Analysis of notch1 protein expression in methotrexate-associated lymphoproliferative disorders.
    Okatani T; Nishimura MF; Egusa Y; Yoshida S; Nishimura Y; Nishikori A; Yoshino T; Yamamoto H; Sato Y
    J Clin Exp Hematop; 2024 Mar; 64(1):1-9. PubMed ID: 38281745
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. CAD204520 Targets
    Pagliaro L; Cerretani E; Vento F; Montanaro A; Moron Dalla Tor L; Simoncini E; Giaimo M; Gherli A; Zamponi R; Tartaglione I; Lorusso B; Scita M; Russo F; Sammarelli G; Todaro G; Silini EM; Rigolin GM; Quaini F; Cuneo A; Roti G
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255842
    [No Abstract]    [Full Text] [Related]  

  • 9. notch1-Induced T-Cell Acute Lymphoblastic leukemia In Vivo Models.
    Campagnari A; Belver L
    Methods Mol Biol; 2024; 2773():9-24. PubMed ID: 38236532
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. IMMUNOPHENOTYPE OF LEUKEMIC CELLS IN CHRONIC LYMPHOCYTIC leukemia PATIENTS WITH notch1 AND SF3B1 GENE MUTATIONS.
    Golyarnik N; Абраменко І; Movchan G; Martina Z; Dyagil I; Chumak A; Bazyka D
    Exp Oncol; 2023 Dec; 45(3):322-327. PubMed ID: 38186023
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Clinical and molecular biological characterization of patients with accelerated chronic lymphocytic leukemia].
    Zhou ZY; Dai LMJ; Sha YQ; Qiu TL; Qin SC; Miao Y; Xia Y; Wu W; Tang HN; Xu W; Li JY; Zhu HY
    Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):917-923. PubMed ID: 38185521
    [No Abstract]    [Full Text] [Related]  

  • 12. Chronic Lymphocytic leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing.
    Grants JM; May C; Bridgers J; Huang S; Gillis S; Meissner B; Boyle M; Ben-Neriah S; Hung S; Duns G; Hilton L; Gerrie AS; Marra M; Kridel R; Sabatini PJB; Steidl C; Scott DW; Karsan A
    Clin Chem; 2024 Jan; 70(1):273-284. PubMed ID: 38175592
    [TBL] [Abstract] [Full Text] [Related]  

  • 13.
    Choi YJ; Min YK; Lee ST; Choi JR; Shin S
    Ann Lab Med; 2024 Jul; 44(4):335-342. PubMed ID: 38145892
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Myeloid/natural killer (NK) cell precursor acute leukemia as a distinct leukemia type.
    Nishimura A; Yokoyama K; Naruto T; Yamagishi C; Imamura T; Nakazono H; Kimura S; Ito M; Sagisaka M; Tanaka Y; Piao J; Namikawa Y; Yanagimachi M; Isoda T; Kanai A; Matsui H; Isobe T; Sato-Otsubo A; Higuchi N; Takada A; Okuno H; Saito S; Karakawa S; Kobayashi S; Hasegawa D; Fujisaki H; Hasegawa D; Koike K; Koike T; Rai S; Umeda K; Sano H; Sekinaka Y; Ogawa A; Kinoshita A; Shiba N; Miki M; Kimura F; Nakayama H; Nakazawa Y; Taga T; Taki T; Adachi S; Manabe A; Koh K; Ishida Y; Takita J; Ishikawa F; Goto H; Morio T; Mizutani S; Tojo A; Takagi M
    Sci Adv; 2023 Dec; 9(50):eadj4407. PubMed ID: 38091391
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. NOTCH pathway mutation contributes to inferior prognosis in HBV-infected chronic lymphocytic leukemia.
    Shang CY; Bei LY; Wu JZ; Sheng HR; Yin H; Liang JH; Wang L; Li JY; Li Y; Xu W
    Ann Hematol; 2024 Mar; 103(3):833-841. PubMed ID: 37993586
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax.
    Jain N; Croner LJ; Allan JN; Siddiqi T; Tedeschi A; Badoux XC; Eckert K; Cheung LWK; Mukherjee A; Dean JP; Szafer-Glusman E; Seymour JF
    Clin Cancer Res; 2024 Feb; 30(3):498-505. PubMed ID: 37955424
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The clinical features and prognostic implications of PTPN11 mutation in adult patients with acute myeloid leukemia in China.
    Yang J; Zhao L; Wu Y; Niu T; Gong Y; Chen X; Huang X; Liu J; Dai Y; Ma H
    Cancer Med; 2023 Dec; 12(23):21111-21117. PubMed ID: 37937729
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Regulatory mechanisms and context-dependent roles of TAL1 in T-cell acute lymphoblastic leukemia.
    Ong JZL; Tan TK; Wang L; Tan SH; Sanda T
    Haematologica; 2024 May; 109(5):1359-1372. PubMed ID: 37855064
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Uncovering notch1 as a Promising Target in the Treatment of
    Fischer J; Erkner E; Fitzel R; Radszuweit P; Keppeler H; Korkmaz F; Roti G; Lengerke C; Schneidawind D; Schneidawind C
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833915
    [No Abstract]    [Full Text] [Related]  

  • 20. Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia.
    Chang YS; Gills JJ; Kawabata S; Onozawa M; Della Gatta G; Ferrando AA; Aplan PD; Dennis PA
    Int J Oncol; 2023 Nov; 63(5):. PubMed ID: 37800623
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 48.